EGF-R POSITIVE NON-SMALL CELL LUNG CANCER
Clinical trials for EGF-R POSITIVE NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EGF-R POSITIVE NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EGF-R POSITIVE NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare lung cancer mutations: targeted pill shows promise
Disease control OngoingThis study tests a daily pill called dacomitinib in 30 people with advanced lung cancer that has uncommon EGFR gene changes. The goal is to see if the drug can shrink tumors or slow the disease. Participants take the drug until it stops working, and they are followed for up to 4 …
Matched conditions: EGF-R POSITIVE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 01, 2026 20:42 UTC
-
New pill targets tough cancers in brain and lungs
Disease control OngoingThis study tests an experimental pill called BDTX-1535 for people with advanced non-small cell lung cancer or a type of brain tumor called glioblastoma that have certain genetic changes. The goal is to find the best dose and see if the drug can shrink tumors or slow their growth.…
Matched conditions: EGF-R POSITIVE NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC